These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19947778)

  • 1. Detecting drug targets with minimum side effects in metabolic networks.
    Li Z; Wang RS; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE.
    Kim HU; Kim TY; Lee SY
    Mol Biosyst; 2010 Feb; 6(2):339-48. PubMed ID: 20094653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systems biology approach to drug discovery.
    Zhu J; Zhang B; Schadt EE
    Adv Genet; 2008; 60():603-35. PubMed ID: 18358334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting complexity and the robustness of network architecture for drug discovery.
    Hellerstein MK
    J Pharmacol Exp Ther; 2008 Apr; 325(1):1-9. PubMed ID: 18202293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining metabolic networks for optimal drug targets.
    Sridhar P; Song B; Kahveci T; Ranka S
    Pac Symp Biocomput; 2008; ():291-302. PubMed ID: 18229694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-efficacy depends on the inhibitor type and the target position in a metabolic network--a systematic study.
    Gerber S; Assmus H; Bakker B; Klipp E
    J Theor Biol; 2008 Jun; 252(3):442-55. PubMed ID: 17981303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computing the shortest elementary flux modes in genome-scale metabolic networks.
    de Figueiredo LF; Podhorski A; Rubio A; Kaleta C; Beasley JE; Schuster S; Planes FJ
    Bioinformatics; 2009 Dec; 25(23):3158-65. PubMed ID: 19793869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting novel pathways in genome-scale metabolic networks.
    Schuster S; de Figueiredo LF; Kaleta C
    Biochem Soc Trans; 2010 Oct; 38(5):1202-5. PubMed ID: 20863284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-scale, constraint-based approach to systems biology of human metabolism.
    Mo ML; Jamshidi N; Palsson BØ
    Mol Biosyst; 2007 Sep; 3(9):598-603. PubMed ID: 17700859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the local optimal solutions of metabolic regulatory networks using information guided genetic algorithm approach and clustering analysis.
    Zheng Y; Yeh CW; Yang CD; Jang SS; Chu IM
    J Biotechnol; 2007 Aug; 131(2):159-67. PubMed ID: 17669537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction networks: from protein functions to drug discovery. A review.
    Chautard E; Thierry-Mieg N; Ricard-Blum S
    Pathol Biol (Paris); 2009 Jun; 57(4):324-33. PubMed ID: 19070972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An iterative algorithm for metabolic network-based drug target identification.
    Sridhar P; Kahveci T; Ranka S
    Pac Symp Biocomput; 2007; ():88-99. PubMed ID: 17992747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network.
    Perumal D; Samal A; Sakharkar KR; Sakharkar MK
    J Drug Target; 2011 Jan; 19(1):1-13. PubMed ID: 20233082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying differentially expressed pathways via a mixed integer linear programming model.
    Qiu YQ; Zhang S; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):475-86. PubMed ID: 19947773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling cellular biochemical reactions via metabolomics-driven approaches.
    Saito N; Ohashi Y; Soga T; Tomita M
    Curr Opin Microbiol; 2010 Jun; 13(3):358-62. PubMed ID: 20430690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can cell systems biology rescue drug discovery?
    Butcher EC
    Nat Rev Drug Discov; 2005 Jun; 4(6):461-7. PubMed ID: 15915152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.